Data / Drug companies / Swati Spentose Private Limited
Swati Spentose Private Limited: 16 products in the FDA NDC directory, labeler code 52119
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Swati Spentose Private Limited (labeler code 52119) lists 16 products in the FDA National Drug Code Directory. By type: 16 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on July 1, 2025.
The request: Watch Swati Spentose Private Limited (FDA labeler code 52119): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52119
- Products in commercial distribution
- 16
- Packages
- 97
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 20, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 16 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 16 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 16 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Silodosin | 52119-025 | Powder | Bulk ingredients | July 1, 2025 |
| Tamsulosin hydrochloride | 52119-024 | Powder | Bulk ingredients | January 5, 2024 |
| Prilocaine | 52119-020 | Powder | Bulk ingredients | March 20, 2023 |
| Pentosan polysulfate sodium | 52119-023 | Powder | Bulk ingredients | January 10, 2023 |
| Melatonin | 52119-017 | Powder | Bulk ingredients | July 1, 2019 |
| Prilocaine hydrochloride | 52119-016 | Powder | Bulk ingredients | July 1, 2019 |
| Meloxicam | 52119-003 | Powder | Bulk ingredients | February 7, 2019 |
| Diphenhydramine hydrochloride | 52119-013 | Powder | Bulk ingredients | May 30, 2016 |
| Diphenhydramine | 52119-012 | Powder | Bulk ingredients | May 30, 2016 |
| Lidocaine hydrochloride | 52119-009 | Powder | Bulk ingredients | March 20, 2014 |
| Lidocaine | 52119-008 | Powder | Bulk ingredients | March 20, 2014 |
| Phenytoin | 52119-007 | Powder | Bulk ingredients | August 20, 2012 |
| Phenytoin sodium | 52119-006 | Powder | Bulk ingredients | August 20, 2012 |
| Pentosan polysulfate sodium | 52119-005 | Powder | Bulk ingredients | August 20, 2012 |
| Lidocaine hydrochloride | 52119-002 | Powder | Bulk ingredients | August 20, 2012 |
| Lidocaine | 52119-001 | Powder | Bulk ingredients | August 20, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.